Stevens Capital Management LP Sells 479 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Stevens Capital Management LP cut its stake in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 74.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 163 shares of the medical instruments supplier's stock after selling 479 shares during the period. Stevens Capital Management LP's holdings in Mettler-Toledo International were worth $244,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. boosted its position in shares of Mettler-Toledo International by 6.6% during the second quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier's stock worth $158,000 after buying an additional 7 shares during the period. DT Investment Partners LLC lifted its stake in Mettler-Toledo International by 13.3% in the 3rd quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier's stock valued at $102,000 after acquiring an additional 8 shares in the last quarter. Suncoast Equity Management boosted its position in Mettler-Toledo International by 2.0% during the 3rd quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier's stock worth $690,000 after acquiring an additional 9 shares during the last quarter. Bleakley Financial Group LLC grew its stake in shares of Mettler-Toledo International by 1.2% during the 3rd quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier's stock worth $1,135,000 after acquiring an additional 9 shares in the last quarter. Finally, Huntington National Bank raised its holdings in shares of Mettler-Toledo International by 20.0% in the third quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier's stock valued at $81,000 after purchasing an additional 9 shares during the last quarter. Institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Price Performance

NYSE MTD traded up $9.63 during trading on Friday, reaching $1,257.54. 108,515 shares of the company's stock were exchanged, compared to its average volume of 136,061. The business has a 50 day moving average price of $1,330.54 and a 200-day moving average price of $1,386.75. The stock has a market capitalization of $26.54 billion, a P/E ratio of 33.90, a PEG ratio of 4.15 and a beta of 1.13. Mettler-Toledo International Inc. has a fifty-two week low of $1,086.88 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The company had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. On average, analysts forecast that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Insider Buying and Selling at Mettler-Toledo International

In other news, insider Gerry Keller sold 140 shares of the company's stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now owns 6 shares of the company's stock, valued at approximately $7,524.54. This represents a 95.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Elisha W. Finney sold 76 shares of the stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the transaction, the director now owns 240 shares in the company, valued at approximately $314,820. This trade represents a 24.05 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on MTD. Evercore ISI increased their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an "in-line" rating in a report on Tuesday, October 1st. Robert W. Baird decreased their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating for the company in a report on Monday, November 11th. Stifel Nicolaus dropped their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating on the stock in a report on Monday, November 11th. Finally, Wells Fargo & Company decreased their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an "equal weight" rating for the company in a research note on Monday, November 11th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Mettler-Toledo International has an average rating of "Hold" and an average target price of $1,338.75.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.